Quanterix (QTRX)
(Real Time Quote from BATS)
$16.03 USD
+0.47 (3.02%)
Updated Apr 29, 2024 01:34 PM ET
4-Sell of 5 4
D Value A Growth B Momentum C VGM
Income Statements
Fiscal Year end for Quanterix Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 122 | 106 | 111 | 86 | 57 |
Cost Of Goods | 52 | 59 | 49 | 38 | 30 |
Gross Profit | 71 | 47 | 62 | 48 | 27 |
Selling & Adminstrative & Depr. & Amort Expenses | 120 | 149 | 120 | 80 | 68 |
Income After Depreciation & Amortization | -50 | -102 | -59 | -32 | -42 |
Non-Operating Income | 2 | 0 | 1 | 0 | 0 |
Interest Expense | -16 | -5 | 0 | 0 | -1 |
Pretax Income | -32 | -97 | -58 | -32 | -41 |
Income Taxes | 1 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -32 | -97 | -58 | -32 | -41 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -32 | -97 | -58 | -32 | -41 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -41 | -87 | -53 | -26 | -38 |
Depreciation & Amortization (Cash Flow) | 8 | 14 | 6 | 5 | 4 |
Income After Depreciation & Amortization | -50 | -102 | -59 | -32 | -42 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 37.59 | 36.99 | 36.00 | 28.60 | 25.09 |
Diluted EPS Before Non-Recurring Items | -0.86 | -2.06 | -1.60 | -1.10 | -1.63 |
Diluted Net EPS (GAAP) | -0.86 | -2.61 | -1.60 | -1.07 | -1.63 |
Fiscal Year end for Quanterix Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 31.55 | 31.33 | 31.03 | 28.46 |
Cost Of Goods | NA | 14.75 | 13.55 | 11.89 | 11.53 |
Gross Profit | NA | 16.80 | 17.78 | 19.14 | 16.93 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 33.75 | 31.55 | 28.70 | 26.35 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -16.95 | -13.77 | -9.56 | -9.42 |
Non-Operating Income | NA | 0.36 | 2.03 | -0.15 | 0.01 |
Interest Expense | NA | -4.32 | -4.19 | -3.89 | -3.45 |
Pretax Income | NA | -12.27 | -7.56 | -5.83 | -5.96 |
Income Taxes | NA | 0.14 | 0.20 | 0.24 | 0.14 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -12.41 | -7.76 | -6.06 | -6.10 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -12.41 | -7.76 | -6.06 | -6.10 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 37.89 | 37.66 | 37.49 | 37.33 |
Diluted EPS Before Non-Recurring Items | NA | -0.33 | -0.21 | -0.16 | -0.16 |
Diluted Net EPS (GAAP) | NA | -0.33 | -0.21 | -0.16 | -0.16 |